Boston Scientific Corporation (NYSE:BSX) is looking for acquisitions. Mike Mahoney, Chief Executive Officer, said "we'll continue to do tuck-in acquisitions that make strategic sense, a strong return on invested capital".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.86 USD | +1.15% | -0.44% | +26.02% |
02/05 | Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing | MT |
02/05 | Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.02% | 107B | |
+7.84% | 218B | |
+7.37% | 184B | |
+13.04% | 135B | |
-1.33% | 62.38B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B | |
+18.76% | 24.39B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Boston Scientific Seeks Acquisitions